Just an article from a Google Alert. SBM has an SGLT2 inhibitor for type2 diabetes that was proven to be more effective than Johnson and Johnsons canagliflozin, which might be called Invokana. Don't think the article means anything for SBM, but....the more you know!

http://diatribe.us/issues/51/learning-curve